AstraZeneca has resumed British clinical trials of its COVID-19 vaccine, one of the most advanced in development, after receiving the green light from safety watchdogs, the company said on Saturday.
Francis Maguire reports.
AstraZeneca has resumed British clinical trials of its COVID-19 vaccine, one of the most advanced in development, after receiving the green light from safety watchdogs, the company said on Saturday.
Francis Maguire reports.
CBS4's Karli Barnett spoke with Dr. Dushyantha Jayaweera, the principal investigator for Janssen’s UM site.
A serious adverse reaction in a volunteer has triggered the safety protocol for the large-scale trial.